Pricing pressures and Middle East unrest hit GSK profits

Article Date: 26/04/2012 07:45
Pricing pressures and Middle East unrest hit GSK profits

Vacancy Search

Quick job search

Advanced Search

Latest News

£132m investment in cancer research at Oxford Uni

£132m investment in cancer research at Oxford Uni

Lilly profits pummelled by generic competition

Lilly profits pummelled by generic competition

Celgene profits leap on multiple myeloma drugs

Celgene profits leap on multiple myeloma drugs

UK £230 million investment to 'revolutionise research'

UK £230 million investment to 'revolutionise research'

Medicines not goods like any other, says new EU president

Medicines not goods like any other, says new EU president

Uproar as doctors get £55 per dementia diagnosis

Uproar as doctors get £55 per dementia diagnosis

Amgen lacks freshness, but is by no means the worst offender

Amgen, heavily castigated this week for overreliance on old products, must feel like it has been unfairly targeted. After all, it is hardly alone in this predicament.

UPDATE: NHS leaders call for £8bn a year to fill cash hole

UPDATE: NHS leaders call for £8bn a year to fill cash hole

Provisional NHS green light for Bayer's Xarelto

Provisional NHS green light for Bayer's Xarelto

Biogen stock hurt by Tecfidera rare brain infection case

Biogen stock hurt by Tecfidera rare brain infection case
more news